Yoneda Labs

San Francisco, California, United States

Drug Development AI drug discovery Clinical Trials Life Sciences

Yoneda Labs was founded by a group from the University of Cambridge with backgrounds in chemistry, robotics, and machine learning. The idea for Yoneda Labs was born when one of the founders, Jan Oboril, was working on drug development at a major pharmaceutical company. He felt he wasted hundreds of hours running trials in the lab that could be replaced with machine learning algorithms that could run the same experiments in silico.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Yoneda Labs on @MedStartr Today #DrugDevelopment #DrugDiscovery #ClinicalTrials #AIDrugDiscovery #LifeSciencesBiopharma #MedMo #MedStartrVentures

https://www.medstartr.ai/s/-chGUJJVTAA

Get Involved in Yoneda Labs

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2023
Website: www.yonedalabs.com/

Disease Areas

Drug Development Drug Discovery Clinical Trials

Technologies

Machine LearningIn Silico DesignAI/ML for Drug DiscoveryComputational Drug Discovery

🌐Website

What do you think of Yoneda Labs?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.